Title : Peficitinib: First Global Approval.

Pub. Date : 2019 Jun

PMID : 31093950






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Peficitinib [Smyraf (Astellas Pharma)] is a Janus kinase (JAK)1, JAK2, JAK3 and tyrosine kinase (Tyk)2 (pan-JAK) inhibitor recently approved in Japan for the treatment of rheumatoid arthritis. peficitinib Janus kinase 3 Homo sapiens